Product Recalls in Georgia

Product recalls affecting Georgia — including food, drugs, consumer products, medical devices, and vehicles distributed to Georgia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,859 recalls have been distributed to Georgia in the last 12 months.

53,623 total recalls
2,859 in last 12 months

Showing 761780 of 13,719 recalls

DrugDecember 16, 2024· SHOPPERS- PLAZA

Recalled Item: FOUZEE SugarLin HERBAL FORMULA capsules Recalled by SHOPPERS- PLAZA Due to...

The Issue: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 16, 2024· FDC Limited

Recalled Item: Ciprofloxacin Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective container: Unable to get the solution out of the bottle as the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2024· SOMERSET THERAPEUTICS LLC

Recalled Item: Atropine Sulfate Ophthalmic Solution Recalled by SOMERSET THERAPEUTICS LLC...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 13, 2024· Amerisource Health Services LLC

Recalled Item: Clobazam Tablets Recalled by Amerisource Health Services LLC Due to Presence...

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Recalled by Akron Pharma, Inc. Due to Labeling: Not Elsewhere...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 50 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Regular Strength Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Buy-Herbal

Recalled Item: Nhan Sam Tuyet Lien Truy Phong Hoan Recalled by Buy-Herbal Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the products to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· GNMart LLC

Recalled Item: FORCE FOREVER 400mg Tablets Recalled by GNMart LLC Due to Marketed without...

The Issue: Marketed without an approved NDA/ANDA. FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Recalled by Ascend Laboratories, LLC Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Recalled by Ascend Laboratories, LLC Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 11, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 11, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· Regenerative Processing Plant, LLC

Recalled Item: LITE Regener-Eyes Recalled by Regenerative Processing Plant, LLC Due to Lack...

The Issue: Lack of Sterility Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund